WallStreetZenWallStreetZen

NYSE: MED
Medifast Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Medifast earnings were $3.6M for the trailing 12 months ending Jun 30, 2025, with -87.7% growth year over year. The latest MED earnings report on Jun 30, 2025 announced Q2 2025 earnings of $2.5M, down 421.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MED reported annual earnings of $2.1M, with -97.9% growth. The next MED earnings date is Nov 10, 2025.

MED past earnings growth

How has MED's earnings growth performed historically?

Company
-87.69%
Industry
16.21%
Market
34.06%
MED's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MED's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MED's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MED earnings history

Current Revenue
$480.4M
Current Earnings
$3.6M
Current Profit Margin
0.8%
MED's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MED Return on Equity

Current Company
1.7%
Current Industry
9.9%
Current Market
30.7%
MED's Return on Equity (1.7%)... subscribe to Premium to read more.
High Return on Equity Performance

MED undefined

Current Company
1.3%
Current Industry
12.1%
MED is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MED announces earnings.

MED undefined

Current Company
0.65%
Current Industry
22%
MED's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MED vs Personal Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MED$19.72M$3.64M-44.90%$0.33
RGS$31.17M$123.54M+34.24%$52.26
PMEC$3.28M-$1.94MN/A-$0.05
YYGH-$3.76M-$4.84MN/A-$0.14
MRM$2.71M$1.01M+34.03%$0.20
View Top Personal Service Stocks

MED earnings dates

Next earnings date
Nov 10, 2025

Medifast Earnings Reports & History FAQ

What were Medifast's earnings last quarter?

On MED's earnings call on Invalid Date, Medifast (NYSE: MED) reported Q2 2025 earnings per share (EPS) of $0.23, up 130.67% year over year. Total MED earnings for the quarter were $2.48 million. In the same quarter last year, Medifast's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Medifast stock.

When does Medifast report earnings?

The next MED earnings call is Invalid Date. Add MED to your watchlist to be reminded of Medifast's next earnings date.

Is Medifast profitable or losing money?

As of the last Medifast earnings report, Medifast is currently profitable. Medifast's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $3.64 million, a 87.6% decrease year over year.

What was MED's earnings growth in the past year?

As of Medifast's earnings date in Invalid Date, Medifast's earnings has grown -87.69% year over year. This is 103.9 percentage points lower than the US Personal Services industry earnings growth rate of 16.21%. MED earnings in the past year totalled $3.64 million.

What are Medifast's earnings expectations?

The current EPS estimate for Medifast's earnings report in Invalid Date is -$0.30.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.